{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:37:58Z","timestamp":1777415878063,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T00:00:00Z","timestamp":1493078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","mayoclinicproceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.mayocp.2017.04.006","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T12:00:19Z","timestamp":1501588819000},"page":"1248-1260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Challenges in Treating Cardiovascular Disease: Restricting Sodium and Managing Hyperkalemia"],"prefix":"10.1016","volume":"92","author":[{"given":"Deborah J.","family":"Clegg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Cody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biff F.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.mayocp.2017.04.006_bib1","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1161\/CIR.0b013e318279acbf","article-title":"Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations","volume":"126","author":"Whelton","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.mayocp.2017.04.006_bib2","unstructured":"US Department of Health and Human Services, US Department of Agriculture. Dietary Guidelines for Americans 2015-2020. 8th ed. Washington, DC: US Department of Agriculture. HHS publication HHS-ODPHP-2015-2020-01-DGA-A. USDA publication Home and Garden Bulletin 232. http:\/\/health.gov\/dietaryguidelines\/2015\/guidelines\/. Published December 2015. Accessed September 30,\u00a02016."},{"issue":"20","key":"10.1016\/j.mayocp.2017.04.006_bib3","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.jacc.2011.01.008","article-title":"ACCF\/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents","volume":"57","author":"Aronow","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.mayocp.2017.04.006_bib4","first-page":"1","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO\u00ae) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"14","key":"10.1016\/j.mayocp.2017.04.006_bib5","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.mayocp.2017.04.006_bib6","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/eurheartj\/ehr379","article-title":"Beyond salt: lifestyle modifications and blood pressure","volume":"32","author":"Frisoli","year":"2011","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.mayocp.2017.04.006_bib7","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/HJH.0000000000000611","article-title":"Daily potassium intake and sodium-to-potassium ratio in the reduction of blood pressure: a meta-analysis of randomized controlled trials","volume":"33","author":"Binia","year":"2015","journal-title":"J\u00a0Hypertens"},{"issue":"4","key":"10.1016\/j.mayocp.2017.04.006_bib8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.mayocp.2016.01.012","article-title":"Achieving the benefits of a high-potassium, Paleolithic diet, without the toxicity","volume":"91","author":"Palmer","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.mayocp.2017.04.006_bib9","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/STROKEAHA.113.004282","article-title":"Potassium intake and stroke risk: a review of the evidence and practical considerations for achieving a minimum target","volume":"45","author":"Hunt","year":"2014","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.mayocp.2017.04.006_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1751-7176.2008.00071.x","article-title":"Hyperkalemia as a constraint to therapy with combination renin-angiotensin system blockade: the elephant in the room","volume":"11","author":"Epstein","year":"2009","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"issue":"9","key":"10.1016\/j.mayocp.2017.04.006_bib11","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3109\/0886022X.2012.717478","article-title":"Major barriers against renin-angiotensin-aldosterone system blocker use in chronic kidney disease stages 3-5 in clinical practice: a safety concern?","volume":"34","author":"Yildirim","year":"2012","journal-title":"Ren Fail"},{"issue":"7","key":"10.1016\/j.mayocp.2017.04.006_bib12","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1056\/NEJMoa1311889","article-title":"Urinary sodium and potassium excretion, mortality, and cardiovascular events","volume":"371","author":"O'Donnell","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mayocp.2017.04.006_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jchf.2015.08.007","article-title":"Impact of dietary sodium restriction on heart failure outcomes","volume":"4","author":"Doukky","year":"2016","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.mayocp.2017.04.006_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jchf.2015.10.003","article-title":"Dietary sodium restriction in heart failure: a recommendation worth its salt?","volume":"4","author":"Hummel","year":"2016","journal-title":"JACC Heart Fail"},{"issue":"6","key":"10.1016\/j.mayocp.2017.04.006_bib15","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMsb1607161","article-title":"Dietary sodium and cardiovascular disease risk\u2014measurement matters","volume":"375","author":"Cogswell","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"25","key":"10.1016\/j.mayocp.2017.04.006_bib16","doi-asserted-by":"crossref","first-page":"e660","DOI":"10.1161\/CIR.0000000000000051","article-title":"Stakeholder discussion to reduce population-wide sodium intake and decrease sodium in the food supply: a conference report from the American Heart Association Sodium Conference 2013 Planning Group","volume":"129","author":"Antman","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.mayocp.2017.04.006_bib17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.phrs.2016.03.037","article-title":"Sodium intake, RAAS-blockade and progressive renal disease","volume":"107","author":"de Borst","year":"2016","journal-title":"Pharmacol Res"},{"issue":"7","key":"10.1016\/j.mayocp.2017.04.006_bib18","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/ndt\/gfv343","article-title":"Balancing wobbles in the body sodium","volume":"31","author":"Titze","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.mayocp.2017.04.006_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/HYPERTENSIONAHA.116.07289","article-title":"Hemodynamics and salt-and-water balance link sodium storage and vascular dysfunction in salt-sensitive subjects","volume":"68","author":"Laffer","year":"2016","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.mayocp.2017.04.006_bib20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11897-013-0145-9","article-title":"What should we tell patients with heart failure about sodium restriction and how should we counsel them?","volume":"10","author":"Lennie","year":"2013","journal-title":"Curr Heart Fail Rep"},{"issue":"12","key":"10.1016\/j.mayocp.2017.04.006_bib21","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1681\/ASN.2013030285","article-title":"A\u00a0randomized trial of dietary sodium restriction in CKD","volume":"24","author":"McMahon","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"7599","key":"10.1016\/j.mayocp.2017.04.006_bib22","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/bmj.39147.604896.55","article-title":"Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the Trials of Hypertension Prevention (TOHP)","volume":"334","author":"Cook","year":"2007","journal-title":"BMJ"},{"issue":"15","key":"10.1016\/j.mayocp.2017.04.006_bib23","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jacc.2016.07.745","article-title":"Sodium intake and all-cause mortality over 20 years in the Trials of Hypertension Prevention","volume":"68","author":"Cook","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.mayocp.2017.04.006_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1681\/ASN.2011040430","article-title":"Sodium intake, ACE inhibition, and progression to ESRD","volume":"23","author":"Vegter","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"20","key":"10.1016\/j.mayocp.2017.04.006_bib25","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1001\/jama.2016.4447","article-title":"Sodium excretion and the risk of cardiovascular disease in patients with chronic kidney disease","volume":"315","author":"Mills","year":"2016","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.mayocp.2017.04.006_bib26","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0002-9343(02)01322-0","article-title":"Peripheral edema","volume":"113","author":"Cho","year":"2002","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.mayocp.2017.04.006_bib27","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3945\/ajcn.110.000174","article-title":"A\u00a0high-sodium diet is associated with acute decompensated heart failure in ambulatory heart failure patients: a prospective follow-up study","volume":"93","author":"Arcand","year":"2011","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"10.1016\/j.mayocp.2017.04.006_bib28","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/eurjhf\/hft097","article-title":"Salt and fluid restriction is effective in patients with chronic heart failure","volume":"15","author":"Philipson","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1016\/j.mayocp.2017.04.006_bib29","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.nut.2004.06.010","article-title":"Effects of a nutritional intervention on body composition, clinical status, and quality of life in patients with heart failure","volume":"20","author":"Col\u00edn Ram\u00edrez","year":"2004","journal-title":"Nutrition"},{"issue":"1","key":"10.1016\/j.mayocp.2017.04.006_bib30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1592\/phco.31.1.58","article-title":"Impact of iatrogenic, excessive, nondietary sodium administration in patients with acute heart failure exacerbation on hospital length of stay","volume":"31","author":"Tafreshi","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.mayocp.2017.04.006_bib31","doi-asserted-by":"crossref","first-page":"f6954","DOI":"10.1136\/bmj.f6954","article-title":"Association between cardiovascular events and sodium-containing effervescent, dispersible, and soluble drugs: nested case-control study","volume":"347","author":"George","year":"2013","journal-title":"BMJ"},{"issue":"16","key":"10.1016\/j.mayocp.2017.04.006_bib32","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: executive summary; a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.mayocp.2017.04.006_bib33","article-title":"2017 ACCF\/AHA Guideline for the Management of Heart Failure","author":"Yancy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mayocp.2017.04.006_bib34","doi-asserted-by":"crossref","unstructured":"National Kidney Foundation. NKF KDOQI Guidelines. K\/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease. New York, NY: National Kidney Foundation. http:\/\/www2.kidney.org\/professionals\/KDOQI\/guidelines_bp\/guide_11.htm. Published 2004. Accessed October 5,\u00a02016.","DOI":"10.1053\/j.ajkd.2004.03.003"},{"issue":"1","key":"10.1016\/j.mayocp.2017.04.006_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/diaclin.34.1.3","article-title":"Standards of medical care in diabetes\u20142016 abridged for primary care providers","volume":"34","year":"2016","journal-title":"Clin Diabetes"},{"issue":"5","key":"10.1016\/j.mayocp.2017.04.006_bib36","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.mayocp.2017.04.006_bib37","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ki.2012.74","article-title":"Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers","volume":"82","author":"Lambers Heerspink","year":"2012","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.mayocp.2017.04.006_bib38","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archinternmed.2009.132","article-title":"The frequency of hyperkalemia and its significance in chronic kidney disease","volume":"169","author":"Einhorn","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.mayocp.2017.04.006_bib39","unstructured":"National Institute for Health and Care Excellence. Chronic kidney disease in adults: assessment and management. Clinical guideline CG182. http:\/\/www.nice.org.uk\/guidance\/cg182. Published July 2014. Updated January 2015. Accessed October 5,\u00a02016."},{"issue":"1","key":"10.1016\/j.mayocp.2017.04.006_bib40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archinte.158.1.26","article-title":"Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors: how much should we worry?","volume":"158","author":"Reardon","year":"1998","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.mayocp.2017.04.006_bib41","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.semnephrol.2014.04.008","article-title":"Prediction and management of hyperkalemia across the spectrum of chronic kidney disease","volume":"34","author":"Lazich","year":"2014","journal-title":"Semin Nephrol"},{"issue":"6","key":"10.1016\/j.mayocp.2017.04.006_bib42","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMra035279","article-title":"Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system","volume":"351","author":"Palmer","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.mayocp.2017.04.006_bib43","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0272-6386(96)90465-5","article-title":"Impact of the initial levels of laboratory variables on survival in chronic dialysis patients","volume":"28","author":"Iseki","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2017.04.006_bib44","doi-asserted-by":"crossref","first-page":"c8","DOI":"10.1159\/000329511","article-title":"Association of hypo- and hyperkalemia with disease progression and mortality in males with chronic kidney disease: the role of race","volume":"120","author":"Hayes","year":"2012","journal-title":"Nephron Clin Pract"},{"issue":"5","key":"10.1016\/j.mayocp.2017.04.006_bib45","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2215\/CJN.04451206","article-title":"Serum and dialysate potassium concentrations and survival in hemodialysis patients","volume":"2","author":"Kovesdy","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.mayocp.2017.04.006_bib46","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.amjcard.2012.01.367","article-title":"Predictors of hyperkalemia and death in patients with cardiac and renal disease","volume":"109","author":"Jain","year":"2012","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.mayocp.2017.04.006_bib47","first-page":"104","article-title":"Short-term mortality risk of serum potassium levels in hypertension: a retrospective analysis of nationwide registry data","volume":"38","author":"Krogager","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mayocp.2017.04.006_bib48","unstructured":"Latts LM, Reaven NL, Funk SE, et\u00a0al. Hyperkalemia is prevalent in patients with cardiorenal comorbidities. Poster presented at: International Society for Pharmacoeconomics and Outcomes Research 20th annual international meeting; May 16-20, 2015; Philadelphia, PA. https:\/\/www.ispor.org\/research_pdfs\/49\/pdffiles\/PCV33.pdf. Accessed January 13,\u00a02017."},{"issue":"16","key":"10.1016\/j.mayocp.2017.04.006_bib49","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJMra020676","article-title":"Renal dysfunction complicating the treatment of hypertension","volume":"347","author":"Palmer","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"11 suppl","key":"10.1016\/j.mayocp.2017.04.006_bib50","first-page":"S212","article-title":"Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors","volume":"21","author":"Epstein","year":"2015","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.mayocp.2017.04.006_bib51","unstructured":"Kayexalate (sodium polystyrene sulfonate) [package insert]. Bridgewater, NJ: Sanofi-aventis US, LLC;\u00a02009."},{"key":"10.1016\/j.mayocp.2017.04.006_bib52","unstructured":"Veltassa (patiromer) [package insert]. Redwood City, CA: Relypsa, Inc;\u00a02016."},{"issue":"12","key":"10.1016\/j.mayocp.2017.04.006_bib53","doi-asserted-by":"crossref","first-page":"e114686","DOI":"10.1371\/journal.pone.0114686","article-title":"Characterization of structure and function of ZS-9, a K+ selective ion trap","volume":"9","author":"Stavros","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.mayocp.2017.04.006_bib54","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1411487","article-title":"Sodium zirconium cyclosilicate in hyperkalemia","volume":"372","author":"Packham","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.mayocp.2017.04.006_bib55","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/1074248416629549","article-title":"Mechanism of action and pharmacology of patiromer, a nonabsorbed cross-linked polymer that lowers serum potassium concentration in patients with hyperkalemia","volume":"21","author":"Li","year":"2016","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.mayocp.2017.04.006_bib56","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1681\/ASN.2010010079","article-title":"Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective?","volume":"21","author":"Sterns","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.mayocp.2017.04.006_bib57","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000360094","article-title":"Potassium-binding resins: associations with serum chemistries and interdialytic weight gain in hemodialysis patients","volume":"39","author":"Jadoul","year":"2014","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.mayocp.2017.04.006_bib58","unstructured":"Alka-Seltzer\u00ae Original product labeling. http:\/\/labeling.bayercare.com\/omr\/online\/alka-seltzer-original.pdf. Published June 16, 2014. Accessed March 27,\u00a02017."},{"issue":"19","key":"10.1016\/j.mayocp.2017.04.006_bib59","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJM199511093331917","article-title":"Declaring the sodium content of drug products","volume":"333","author":"Szarfman","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.mayocp.2017.04.006_bib60","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2014.15688","article-title":"Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial","volume":"312","author":"Kosiborod","year":"2014","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.mayocp.2017.04.006_bib61","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/ejhf.300","article-title":"Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial","volume":"17","author":"Anker","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1016\/j.mayocp.2017.04.006_bib62","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2215\/CJN.01170216","article-title":"Effect of patiromer on urinary ion excretion in healthy adults","volume":"11","author":"Bushinsky","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.mayocp.2017.04.006_bib63","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1410853","article-title":"Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors","volume":"372","author":"Weir","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.mayocp.2017.04.006_bib64","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jama.2015.7446","article-title":"Effect of patiromer on serum potassium level in patients with hyperkalemia and diabetic kidney disease: the AMETHYST-DN randomized clinical trial","volume":"314","author":"Bakris","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.mayocp.2017.04.006_bib65","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/ki.2015.270","article-title":"Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia","volume":"88","author":"Bushinsky","year":"2015","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.mayocp.2017.04.006_bib66","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10741-005-2343-3","article-title":"Aldosterone biosynthesis, regulation, and classical mechanism of action","volume":"10","author":"Williams","year":"2005","journal-title":"Heart Fail Rev"},{"issue":"3","key":"10.1016\/j.mayocp.2017.04.006_bib67","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.kint.2016.04.019","article-title":"Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors","volume":"90","author":"Weir","year":"2016","journal-title":"Kidney Int"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619617303099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619617303099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T22:19:39Z","timestamp":1569968379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619617303099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":67,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0025619617303099"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2017.04.006","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in Treating Cardiovascular Disease: Restricting Sodium and Managing Hyperkalemia","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2017.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}